MŁMichał Łebek

Michał Łebek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michał Łebek has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ISOTRETINOIN AND MOOD DISORDERS IN PATIENTS WITH ACNE VULGARIS - LITERATURE REVIEW

    by Dominika Weronika Brożyna, Jarosław Dudek, Wojciech Kukiełka, Damian GręBosz, Wiktoria Komornik, Michał Łebek, Mateusz WnęK, Michalina Pastuszka, Bartłomiej Andrzej Sałapski, Wiktor Zdeb

    Introduction and Aim: Acne vulgaris is among the most prevalent dermatological conditions affecting adolescents and young adults. Visible acne lesions may considerably reduce quality of life, negatively influence self-esteem, and impair social functioning. Oral isotretinoin is widely considered the treatment of choice for severe and therapy-resistant acne. Nevertheless, concerns have long been raised regarding its potential association with psychiatric symptoms, particularly mood disturbances, depression, and suicidal behaviour. The purpose of this review is to summarise current clinical evidence concerning the relationship between isotretinoin therapy and mood disorders in patients with acne vulgaris, with particular attention to factors that may explain the observed clinical outcomes. Material and Methods: A narrative literature review was performed using advanced searches in the PubMed database. The analysis included English-language publications from the last five years, such as clinical and observational studies, systematic reviews, and meta-analyses focusing on depressive symptoms, psychiatric adverse events, and quality-of-life changes among patients receiving isotretinoin for acne vulgaris. Conclusions: The currently available evidence does not conclusively demonstrate a clinically meaningful increase in depression risk in the general population of patients treated with isotretinoin. However, in some individuals, specific vulnerability factors may increase susceptibility to mood disturbances, supporting the need for careful psychological monitoring during therapy. In many patients, improvement in acne severity is accompanied by better well-being and enhanced quality of life. Further research is required to clarify the neurobiological mechanisms underlying isotretinoin activity and to identify patients at greatest risk of psychiatric complications. These findings emphasize the importance of individualized risk–benefit assessment and close cooperation between dermatologists, general practitioners, and mental health specialists.

  • Open Access

    IMPACT OF OPIOID DEPRESCRIBING AND TAPERING ON MENTAL HEALTH AND SOCIAL FUNCTIONING IN PATIENTS WITH CHRONIC NON – CANCER PAIN: AN OVERVIEW OF CURRENT EVIDENCE

    by Mateusz WnęK, Michał Adam Łebek, Wiktoria Zofia Komornik, Jakub Jan Piec, Damian GręBosz, Wojciech Kukiełka, Bartłomiej Andrzej Sałapski, Dominika Weronika Brożyna, Jarosław Dudek, Jakub Dawid Gałwiaczek

    Background. Long-term opioid therapy for chronic non-cancer pain is associated with numerous adverse effects, including psychological distress, dependence, and impaired functioning. In response to growing concerns about opioid-related harms, opioid deprescribing and tapering strategies have gained increasing attention in clinical practice. However, their impact on patients’ mental health and social functioning remains incompletely understood. Aim. This review aimed to evaluate the available evidence on the effects of opioid deprescribing and tapering on mental health and social functioning in patients with chronic non-cancer pain. Material and methods. A literature review was conducted using major biomedical databases, including PubMed, MEDLINE, Scopus, Web of Science, and the Cochrane Library. Eligible studies included peer-reviewed articles examining opioid deprescribing or tapering in adults with chronic non-cancer pain and reporting outcomes related to mental health, social functioning, or patient-reported functioning Results. The available evidence suggests that patients undergoing opioid deprescribing frequently present with substantial psychological distress, including depression, anxiety, and pain catastrophizing. Mental health outcomes during tapering are heterogeneous and influenced by the pace of dose reduction, patient involvement in decision making, and access to psychological support. Qualitative studies commonly highlight social factors: stigma, communication with healthcare providers, and availability of alternative pain management strategies. Conclusions. Opioid deprescribing in patients with chronic non-cancer pain represents a complex clinical process with potential implications for both mental health and social functioning. Individualized tapering strategies, patient involvement in treatment decisions, and adequate psychological and multidisciplinary support appear essential for minimizing adverse outcomes and improving patient experiences during opioid dose reduction.

  • Open Access

    The Role of GLP-1 Receptor Agonists in the Management of Polycystic Ovary Syndrome: A Narrative Review

    by Angelika Juszczyk, Sylwia Pietrajtis, Bartłomiej Sałapski, Dominika Brożyna, Mateusz Kubicki, Damian GręBosz, Jakub Piec, Wiktoria Komornik, Michał Łebek, Krzysztof Lis

    Background: Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Insulin resistance and obesity are frequent components of this syndrome and further worsen the associated hormonal disturbances and infertility. Aim: The aim of this narrative review is to explore the potential role of GLP-1 receptor agonists (GLP-1 RAs) in the management of women with PCOS, with particular focus on their effects on blood glucose fluctuations and excess body weight, both of which are important targets in PCOS treatment. Methods: The literature search was conducted using the PubMed database in order to find articles reporting on the mechanism of action of GLP-1 RAs, the results of their use in PCOS treatment, and their adverse effects. The authors included articles published between 2020 and 2026. Results: GLP-1 RAs exhibit pleiotropic metabolic effects, including the regulation of insulin and glucagon secretion, protective effects on pancreatic beta-cells, and modulation of appetite and energy intake. These mechanisms may contribute to the beneficial clinical outcomes observed in women with PCOS. Current clinical studies and meta-analyses have demonstrated the positive effects of GLP-1 RAs on anthropometric parameters, glucose metabolism, and selected reproductive and hormonal functions, particularly when used in combination with metformin. Adverse effects associated with these agents are mainly gastrointestinal and generally diminish over the course of treatment. Conclusions: GLP-1 RAs appear to represent a promising therapeutic approach for women with PCOS. However, further studies are required to evaluate the long-term effects of their use in this patient population.

  • Open Access

    Patent Foramen Ovale as a Risk Factor for Neurological Decompression Sickness in Recreational Divers: A Narrative Review

    by Sylwia Pietrajtis, Angelika Juszczyk, Dominika Brożyna, Mateusz WnęK, Bartłomiej Sałapski, Mateusz Kubicki, Wojciech Kukiełka, Michał Łebek, Wiktoria Komornik, Jakub Gałwiaczek

    Background. Decompression sickness (DCS) remains a relevant risk in recreational and professional diving. It results from inert gas (mainly nitrogen) uptake under increased pressure and subsequent bubble formation during ascent. These bubbles may affect tissues and circulation. Neurological DCS is the most severe form and may lead to permanent disability or death.Patent foramen ovale (PFO), present in approximately 25% of adults, may enable right-to-left shunting and allow venous gas emboli to bypass pulmonary filtration. This mechanism is considered a potential contributor to paradoxical embolization and central nervous system involvement. Aim. The aim of this review is to evaluate current evidence on the association between PFO and neurological DCS in recreational divers, with emphasis on diagnostic methods and clinical implications. Materials and methods. A narrative review of English-language publications (2015-2026) was conducted using PubMed and selected peer-reviewed journals in diving and cardiovascular medicine. Original research articles, systematic reviews, meta-analyses, and guidelines were included. Results. Available evidence suggests that PFO, particularly with large or high-grade right-to-left shunts, is associated with increased risk of neurological DCS. Paradoxical embolization is considered the main underlying mechanism. Diagnostic evaluation is based primarily on contrast echocardiography and transcranial Doppler. Conclusions. PFO constitutes an important but not exclusive risk factor for neurological DCS. The functional characteristics of the shunt appear to influence this risk. Routine screening is not currently recommended. Targeted evaluation and individualized risk assessment should be considered. Further prospective studies are needed to clarify optimal screening strategies and indications for PFO closure in recreational divers.

  • Open Access

    The Role of Resistance Training in the Non-Pharmacological Management of Hypertension in Adults Over 50: A Narrative Review

    by Jakub Gałwiaczek, Jarosław Dudek, Michał Łebek, Wiktoria Komornik, Wiktor Zdeb, Damian GręBosz, Jakub Piec, Angelika Juszczyk, Sylwia Pietrajtis, Krzysztof Lis

    Background. Hypertension remains a major cardiovascular risk factor, particularly in older adults, and non-pharmacological interventions are increasingly emphasized. Aim. The aim of this narrative review was to evaluate the role of resistance training in the management of hypertension in adults over 50. The paper focuses on its effects on blood pressure, possible mechanisms, and clinical relevance. Methods. A narrative review design was used. The analysis was based on current clinical guidelines and selected randomized controlled trials, systematic reviews, and meta-analyses related to resistance training and blood pressure. Studies involving older adults and different resistance training modalities were included. Results. Evidence from meta-analyses indicates that resistance training can reduce both systolic and diastolic blood pressure. This has been observed in older adults with prehypertension and diagnosed hypertension. The effect is usually moderate, with decreases of around 3-8 mm Hg in systolic blood pressure and smaller changes in diastolic values. Several mechanisms have been proposed, including endothelial function, vascular compliance, and autonomic regulation, although their exact contribution is not always clear. Different forms of resistance training, such as dynamic, circuit-based, and isometric exercise, seem to have beneficial effects, but results vary depending on training parameters. Conclusions. Resistance training can be considered a useful part of non-pharmacological management of hypertension in adults over 50. It should be treated as a complementary strategy, alongside other lifestyle modifications and pharmacological treatment when needed. Further research is still needed to better define optimal training protocols and understand individual differences.